m
Recent Posts
Connect with:
Wednesday / August 17.
HomeminewsMiSight 1 day Expands Myopia Spherical Prescriptions

MiSight 1 day Expands Myopia Spherical Prescriptions

Higher prescriptions are now available in CooperVision’s MiSight 1 day contact lenses. The expanded range – covering -0.25D to -10.00D (0.50D steps after -6.00D) –means that MiSight 1 day covers 99.97% of prescriptions for Asian and Caucasian children – who have myopia and less than 1D of astigmatism.1 The diopter extension for this innovative, specially designed lens will allow even more children to benefit from myopia management.

MiSight1 day contact lenses are backed by the longest-running soft contact lens study among children. The clinical trial has proven that MiSight 1 day works for nearly all children with myopia2† cuts myopia progression by half, works at any age a child starts treatment (8+),3║ works for as long as the child wears them3║ and that myopia control benefits from MiSight 1 day are retained after treatment.4,5*

MiSight 1 day covers 99.97% of prescriptions for Asian and Caucasian children – who have myopia and less than 1D of astigmatism

With myopia on the rise globally,6 an increasing number of children may require the higher prescriptions that MiSight 1 day lenses will offer.

“Every diopter matters, particularly for children whose myopia progression may have already placed them at a higher risk for conditions such as myopic maculopathy and glaucoma.7 While early treatment is best, it’s never too late to start,” said Elizabeth Lumb, BSc (Hons) MCOptom, FBCLA, Director of Global Professional Affairs, Myopia Management, CooperVision. “Even older children starting with MiSight 1 day have seen their myopia progression cut by half.”3║

As a global leader in myopia control and management for children, CooperVision believes that options must be available for as many children as possible. With MiSight 1 day’s range extension, eye care professionals in Australia and New Zealand and in more than 30 other countries can have an even greater impact.

†90% of myopic eyes respond to MiSight 1 day treatment; ages 11-15 at start of wear, n=90.
§Using measured and modeled data, pooled across ages (8-17), MiSight 1 day slowed myopia progression by an average of approximately 50%.
║Children with myopia fit with MiSight 1 day contact lenses ages 8-15 continued to experience slowed myopia progression as long as they remained in treatment.
*12 months post-treatment, evidence indicates that no accumulated myopia control benefits were lost following 3 or 6-years of MiSight 1 day wear (on average, for children aged 8-15 at start of wear). Instead, eye growth reverted to expected, age average myopic progression rates.

References
1. CVI Data on file, 2022. SERE coverage of childhood myopia prescriptions with MiSight 1 day for 104,810 eyes in Asia (China, Korea) and 116,336 eyes in Europe and USA aged 8-18 years.
2. Chamberlain P et al. Long-Term Effect of Dual-Focus Contact Lenses on Myopia Progression in Children: A 6-year Multicenter Clinical Trial. Optom Vis Sci 2022 In Press.
3. Arumugam B, Bradley A, Hammond D, Chamberlain P. Modelling Age Effects of Myopia Progression for the MiSight 1 day Clinical Trial. Invest. Ophthalmol. Vis. Sci. 2021;62(8):2333.
4. Chamberlain P, Arumugam B, et al. Myopia progression on cessation of Dual-Focus contact lens wear: MiSight 1 day 7 year findings. Optom Vis Sci 2021;98:E-abstract 210049.
5 Hammond D, Arumugam B, et al. Myopia Control Treatment Gains are Retained after Termination of Dual-focus Contact Lens Wear with no Evidence of a Rebound Effect. Optom Vis Sci 2021;98:E-abstract 215130.
6.i Holden et al, Global Prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology 2016. 123(5):1036-1042.
7. Bullimore et al. Myopia Control: Why Each Diopter Matters Optom Vis Sci 2019;96:463–465.

DECLARATION

DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.